Ladenburg Thalmann Financial Services’s Amicus Therapeutics FOLD Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$3K	Buy	271 +131	+94%	+$1.2K	﹤0.01%	4955
2019 Q3	$1K	Hold	140	–	–	﹤0.01%	5107
2019 Q2	$2K	Buy	140 +88	+169%	+$1.12K	﹤0.01%	4963
2019 Q1	$1K	Sell	52 -2,079	-98%	-$25.4K	﹤0.01%	5066
2018 Q4	$21K	Hold	2,131	–	–	﹤0.01%	3845
2018 Q3	$26K	Buy	2,131 +1,826	+599%	+$25.5K	﹤0.01%	3737
2018 Q2	$5K	Hold	305	–	–	﹤0.01%	4580
2018 Q1	$5K	Hold	305	–	–	﹤0.01%	4580
2017 Q4	$5K	Hold	305	–	–	﹤0.01%	4509
2017 Q3	$5K	Buy	305 +55	+22%	+$728	﹤0.01%	4389
2017 Q2	$3K	Hold	250	–	–	﹤0.01%	4469
2017 Q1	$2K	Buy	+250	New	+$1.58K	﹤0.01%	4562

Other funds holding FOLD

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Ladenburg Thalmann Financial Services's FOLD Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Amicus Therapeutics (FOLD) stake by 94% in Q4 2019, buying an estimated $1.2K and bringing the position to 271 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #4955.

Ladenburg Thalmann Financial Services first reported a position in FOLD in Q1 2017 and has held it in 12 quarters since. The position peaked at $26K in Q3 2018. 224 funds tracked by Wall St. Rank hold FOLD as of Q4 2019.

Ladenburg Thalmann Financial Services held 271 shares of Amicus Therapeutics worth $3K as of Q4 2019.
Ladenburg Thalmann Financial Services bought 131 Amicus Therapeutics shares in Q4 2019, an estimated $1.2K.
Amicus Therapeutics made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4955 holding.
Ladenburg Thalmann Financial Services first reported a position in Amicus Therapeutics in Q1 2017 and has held it in 12 quarters since.
Ladenburg Thalmann Financial Services's Amicus Therapeutics position peaked at $26K in Q3 2018.
224 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.